Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy

BACKGROUND: This post hoc analysis assessed clinical and functional responses to tofacitinib monotherapy, tofacitinib + methotrexate (MTX), and adalimumab + MTX, in patients with rheumatoid arthritis enrolled in the ORAL Strategy study, including evaluation of patient-level data using cumulative pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Tsutomu, Fleischmann, Roy, Iikuni, Noriko, Shi, Harry, Soma, Koshika, Paulissen, Jerome, Hirose, Tomohiro, Smolen, Josef S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383419/
https://www.ncbi.nlm.nih.gov/pubmed/34429160
http://dx.doi.org/10.1186/s13075-021-02591-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383419/
https://www.ncbi.nlm.nih.gov/pubmed/34429160
http://dx.doi.org/10.1186/s13075-021-02591-y

Ejemplares similares